Another syndrome which seems to possibly benefit from INS supplementation is polycystic ovary syndrome (PCOS), where MI demonstrated results similar to metformin in terms of homeostatic model assessment-insulin resistance (HOMA-IR) reduction and other metabolic outcomes such as BMI and menstrual cycle improvement [10,24,35]. Here, INS is linked to Insulin resistance.